NIH-funded research R21 grant

Investigating how astrocytes affect the blood-brain barrier after a stroke

Official title: Astrocytic NBCe1 in regulation of blood brain barrier integrity

Funded at University of Pittsburgh at Pittsburgh · NIH-10810958 · Data updated 2026-11-12

This study is looking at how a type of brain cell called astrocytes helps protect the blood-brain barrier after a stroke, and it hopes to find new ways to help people recover from strokes by understanding what happens when these cells don't work properly.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 11, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$428,400
NIH project number1R21NS131754-01A1
Project IDNIH-10810958 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced an ischemic stroke and are experiencing neurological impairments.

Less likely to help

Patients who have not had a stroke or have other unrelated neurological conditions may not benefit from this research.

What this research studies

This research focuses on understanding the role of astrocytes, a type of brain cell, in maintaining the integrity of the blood-brain barrier (BBB), particularly after an ischemic stroke. The study examines how dysfunction in astrocytes can lead to BBB disruption, which is a critical factor in brain damage following a stroke. By exploring the mechanisms of a specific transporter protein, NBCe1, in astrocytes, the research aims to uncover how these cells contribute to BBB regulation and the potential consequences of their dysfunction. Patients may benefit from insights gained that could lead to new therapeutic strategies for stroke recovery.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that protect the blood-brain barrier and improve recovery outcomes for stroke patients.

How similar studies have gone: Previous research has shown that targeting astrocyte function can lead to improvements in brain health after injury, suggesting that this approach may hold promise.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Begum, Gulnaz — University of Pittsburgh at Pittsburgh
  • Study coordinator: Begum, Gulnaz

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.